Beltone’s Midcap Fund Buys 25 Percent of Bio Pharma (MENA)

Source: Amwal Al Ghad

Beltone Private Equity, the private equity subsidiary of Egyptian investment firm Beltone Financial, has invested EGP10 million (approximately US$1.6 million) for a 25 percent stake in Bio Pharma Egypt, a manufacturer of private label and branded nutritional supplements. Bio Pharma Egypt plans to use the funding to raise its production capacity and to launch new products.